Joel Neal, MD, PhD
Publication Details
-
A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.
J Thorac Oncol. 2012; (10): 1602-8
This investigator-initiated study explores the safety, maximum tolerated dose, clinical response, and pharmacokinetics of hydroxychloroquine (HCQ) with and without erlotinib in patients with advanced non-small-cell lung cancer.
Help